What Stocks Are Recession-Proof?
Fears of a recession prevailed in Q2 2025 when the…
Buy
62
BMRN Quote, Financials, Valuation and Earnings
Last price:
$58.69
Seasonality move
:
3.2%
Day range:
$59.39 - $61.30
52-week range:
$52.93 - $94.85
Dividend yield:
0%
P/E ratio:
22.22x
P/S ratio:
4.01x
P/B ratio:
1.98x
Volume:
1.7M
Avg. volume:
1.9M
1-year change:
-25.74%
Market cap:
$11.5B
Revenue:
$2.9B
EPS (TTM):
$2.69
BMRN Analysts' Consensus Rating
The 22 analysts providing 12-month price projections for Biomarin Pharmaceutical shares anticipate an average target of $96.02, ranging from a low estimate of $65.00 to a high estimate of $126.00. This average target implies a growth of 60.62% compared to the current stock price of $59.78.
Consensus Price Target
$96.02
Highest Price Target
$126.00
Lowest Price Target
$65.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 14 | 16 | 16 |
| Hold | 7 | 6 | 6 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Buy | Buy |
BMRN Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Which Stocks Are Recession-Proof?
Fears of a recession prevailed in Q2 2025 when the…
Is Gartner a Safe Stock to Own?
Gartner (NYSE:IT) is among the world’s largest consulting, research and…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 38x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
70
Is NVDA Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 44x
Alerts
Buy
57
RGC alert for May 14
Regencell Bioscience Holdings [RGC] is up 8.9% over the past day.
Buy
54
HALO alert for May 14
Halozyme Therapeutics [HALO] is down 4.72% over the past day.
Buy
91
COIN alert for May 14
Coinbase Global [COIN] is up 2.36% over the past day.
